Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/15/2025
Gardasil9 Gains Expanded Approval in China
4/14/2025
China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...
4/9/2025
China Launches Phase I Trial for Nation's First Monkeypox Vaccine
4/9/2025
RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG
4/9/2025
Newish Tech Secures Series B Financing to Advance Next-Gen Cancer Vacc...
4/8/2025
Asia-Pacific Vaccine Market Set for Steady Growth Through 2035 Despite...
4/8/2025
Akeso Initiates Investigator-Initiated Trial for Personalized mRNA Vac...
4/5/2025
BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...
4/1/2025
China Accelerates Brain Chip Trials After Initial Success
4/1/2025
Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
3/28/2025
Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...
3/27/2025
Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)
3/25/2025
Everest Announces FDA Clearance of IND Application for Tumor-Associate...
3/24/2025
GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
3/21/2025
Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...
3/21/2025
Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...
3/21/2025
Gilead's Trodelvy Receives Second Approval in China
3/19/2025
MSD Expands Public Health Efforts in China Following HPV Vaccine Appro...
3/14/2025
BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...
3/12/2025
Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...
3/11/2025
Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...
3/4/2025
Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...
2/28/2025
NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...
2/28/2025
SciClone Secures Rights to Eisai's Tasurgratinib for Greater China
2/25/2025
Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...
2/25/2025
BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial
2/21/2025
NMPA Announces Package Insert Revision of Fluorouracil Injection
2/20/2025
Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...
2/14/2025
NMPA Approves SciClone's Vibativ for Drug-Resistant Gram-Positive Infe...
2/14/2025
China's Health Insurance Premiums Reached $134B in 2024, Up 8.2% YoY
Page:
1
/
71
Total number of articles:
2126
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit